TY - JOUR
T1 - Supportive care 2030 movement
T2 - towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study
AU - Multinational Association of Supportive Care in Cancer (MASCC) Study Group Chairs
AU - Chan, Raymond Javan
AU - Knowles, Reegan
AU - Ashbury, Fredrick D.
AU - Bowen, Joanne
AU - Chan, Alexandre
AU - Chin, Melissa
AU - Olver, Ian
AU - Taylor, Carolyn
AU - Tinianov, Stacey
AU - Alberti, Paola
AU - Bossi, Paolo
AU - Brito-Dellan, Norman
AU - Cooksley, Tim
AU - Crawford, Gregory Brian
AU - Dixit, Niharika
AU - Fitch, Margaret I.
AU - Freedman, Jason L.
AU - Ginex, Pamela K.
AU - Hart, Nicolas H.
AU - Hertz, Daniel L.
AU - Jefford, Michael
AU - Koczwara, Bogda
AU - Naito, Tateaki
AU - Orsey, Andrea Dahlman
AU - Ruhlmann, Christina H.
AU - Tsoukalas, Nikolaos
AU - van den Hurk, Corina
AU - Van Sebille, Ysabella
AU - Wardill, Hannah Rose
AU - Scotte, Florian
AU - Lustberg, Maryam
N1 - Publisher Copyright:
© 2024
PY - 2024/10/1
Y1 - 2024/10/1
N2 - Background: Supportive care to ensure optimal quality of life is an essential component of cancer care and symptom control across the lifespan. Ongoing advances in cancer treatment, increasing toxicity from many novel treatment regimes, and variations in access to care and cancer outcomes across the globe and resource settings present significant challenges for supportive care delivery. To date, no overarching framework has been developed to guide supportive care development worldwide. As an initial step of the Multinational Association of Supportive Care in Cancer (MASCC) Supportive Care 2030 Movement, we developed a targeted, unifying set of ambition statements to envision the future of supportive cancer care. Methods: From September 2022 until June 2023, we used a modified Delphi methodology to develop and attain consensus about ambition statements related to supportive cancer care. Leaders of MASCC Study Groups were invited to participate in an Expert Panel for the first two Delphi rounds (and a preliminary round to suggest potential ambition statements). Patient Advocates then examined and provided input regarding the ambition statements. Findings: Twenty-seven Expert Panelists and 11 Patient Advocates participated. Consensus was attained on 13 ambition statements, with two sub-statements. The ambition statements addressed global standards for guideline development and implementation, coordinated and individualized care, dedicated supportive oncology services, self-management, needs for screening and actions, patient education, behavioral support, financial impact minimization, comprehensive survivorship care, and timely palliative care, reflecting collaboration, coordination and team-based approach across all levels. Interpretation: This study is the first to develop shared ambitions for the future of supportive cancer care on a global level. These ambition statements can facilitate a coordinated, resource-stratified, and person-centered approach and inform research, education, clinical services, and policy efforts. Funding: This project received funding support from Prof Raymond Chan's NHMRC Investigator Grant (APP1194051).
AB - Background: Supportive care to ensure optimal quality of life is an essential component of cancer care and symptom control across the lifespan. Ongoing advances in cancer treatment, increasing toxicity from many novel treatment regimes, and variations in access to care and cancer outcomes across the globe and resource settings present significant challenges for supportive care delivery. To date, no overarching framework has been developed to guide supportive care development worldwide. As an initial step of the Multinational Association of Supportive Care in Cancer (MASCC) Supportive Care 2030 Movement, we developed a targeted, unifying set of ambition statements to envision the future of supportive cancer care. Methods: From September 2022 until June 2023, we used a modified Delphi methodology to develop and attain consensus about ambition statements related to supportive cancer care. Leaders of MASCC Study Groups were invited to participate in an Expert Panel for the first two Delphi rounds (and a preliminary round to suggest potential ambition statements). Patient Advocates then examined and provided input regarding the ambition statements. Findings: Twenty-seven Expert Panelists and 11 Patient Advocates participated. Consensus was attained on 13 ambition statements, with two sub-statements. The ambition statements addressed global standards for guideline development and implementation, coordinated and individualized care, dedicated supportive oncology services, self-management, needs for screening and actions, patient education, behavioral support, financial impact minimization, comprehensive survivorship care, and timely palliative care, reflecting collaboration, coordination and team-based approach across all levels. Interpretation: This study is the first to develop shared ambitions for the future of supportive cancer care on a global level. These ambition statements can facilitate a coordinated, resource-stratified, and person-centered approach and inform research, education, clinical services, and policy efforts. Funding: This project received funding support from Prof Raymond Chan's NHMRC Investigator Grant (APP1194051).
KW - Optimal care
KW - Palliative care
KW - Supportive care
KW - Supportive oncology
KW - Toxicity
UR - http://www.scopus.com/inward/record.url?scp=85203456196&partnerID=8YFLogxK
U2 - 10.1016/j.eclinm.2024.102825
DO - 10.1016/j.eclinm.2024.102825
M3 - Article
AN - SCOPUS:85203456196
SN - 2589-5370
VL - 76
JO - eClinicalMedicine
JF - eClinicalMedicine
M1 - 102825
ER -